Inventor · Berkeley Heights, NJ, US

Benjamin Mugrage

22Patents
6h-index
27Co-inventors
69Inventor score

Filing activity: Jun 21, 1991 → Dec 12, 2017

Most-cited inventions

PatentTitleAreaCited byStatus
US9181184B2 Method for the treatment of pompe disease using 1-deoxynojirimycin and derivatives Chemistry; Metallurgy 25 Active
US6174888A 2-amino-7-(1-substituted-2-hydroxyethyl)-3,5-dihydropyrrolo[3,2-D]pyrimidin -4-ones Human Necessities 23 Expired
US6291523A Certain 5-alkyl-2-arylaminophenylacetic acids and derivatives Human Necessities 22 Expired
US6310099A Certain 5-alkyl-2-arylaminophenylacetic acids and derivatives Human Necessities 15 Expired
US9273031B2 Combination therapy with MDM2 and EFGR inhibitors Chemistry; Metallurgy 12 Active
US7501439B2 Tartrate salt of isofagomine and methods of use Human Necessities 6 Active
US5180718A Acyl derivatives of oxazolorifamycins Chemistry; Metallurgy 5 Expired
US8658170B2 Combination therapy with MDM2 and EFGR inhibitors Chemistry; Metallurgy 4 Active
US6043365A Preparation of 2-amino-7-(1-substituted-2-hydroxyethyl)-3, 5-dihydropyrrolo[3,2-d]pyrimidin-4-ones Emerging Cross-Sectional Technologies 2 Expired
US7202364B2 Certain phenylacetic acids and derivatives Chemistry; Metallurgy 2 Expired
US7115662B2 Certain 5-alkyl-2-arylaminophenylacetic acids and derivatives Human Necessities 2 Expired
US6727281B2 Certain 5-alkyl-2-arylaminophenylacetic acids and derivatives Human Necessities 1 Expired
US8618302B2 Methods and compositions of targeted drug development Physics 1 Active
US6451858B2 Certain 5-alkyl-2-arylaminophenylacetic acids and derivatives Human Necessities 1 Expired
US8362294B2 Phenylacetic acid derivatives Chemistry; Metallurgy 0 Active
US7863453B2 Tartrate salt of isofagomine and methods of use Human Necessities 0 Active
US9023354B2 Combination therapy with MDM2 and EFGR inhibitors Chemistry; Metallurgy 0 Active
US8586782B2 Phenylacetic acid derivatives Chemistry; Metallurgy 0 Active
US5576439A Dihydropyridinecarboxylic acid anhydrides Chemistry; Metallurgy 0 Expired
US11602528B2 Method for the treatment of Pompe disease using 1-deoxynojirimycin derivatives Chemistry; Metallurgy 0 Active
US9238641B2 Combination therapy with MDM2 and EFGR inhibitors General 0 Revoked
US9073858B2 Methods of targeted drug development Physics 0 Active

Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.